tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Robert Driscoll, 317 are a BUY (90.83%), 30 are a HOLD (8.6%), 2 are a SELL (0.57%).
Analyst Robert Driscoll, currently employed at WEDBUSH, carries an average stock price target met ratio of 41.79% that have a potential upside of 49.51% achieved within 242 days.
Robert Driscoll’s has documented 674 price targets and ratings displayed on 46 stocks. The coverage is on Healthcare, Energy sectors.
Most recent stock forecast was given on CRBP, Corbus Pharmaceuticals.
Analyst best performing recommendations are on ABUS (ARBUTUS BIOPHARMA CORP).
The best stock recommendation documented was for ABUS (ARBUTUS BIOPHARMA CORP) at 10/9/2018. The price target of $5 was fulfilled within 1 day with a profit of $1 (16.67%) receiving and performance score of 166.67.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 15-Sep-2020
$5
$1.34 (36.61%)
$5
8 months 8 days ago
(04-Mar-2026)
10/15 (66.67%)
$0.25 (5.26%)
442
Buy Since 05-Nov-2021
$5
$1.34 (36.61%)
$5
1 years 7 months 12 days ago
(31-Mar-2025)
4/9 (44.44%)
$1.51 (43.27%)
420
Buy Since 17-Dec-2020
$5
$1.34 (36.61%)
$5
1 years 9 months 22 days ago
(21-Jan-2025)
5/19 (26.32%)
$1.79 (55.76%)
671
Hold Since 29-Dec-2021
$5
$1.34 (36.61%)
$4
4 years 9 months 10 days ago
(02-Feb-2022)
2/2 (100%)
$2.11 (73.01%)
1298
Buy Since 05-Mar-2020
$7
$3.34 (91.26%)
$7
5 years 4 months 15 days ago
(28-Jun-2021)
0/6 (0%)
$3.63 (107.72%)
Which stock is Robert Driscoll most bullish on?
Which stock is Robert Driscoll most reserved on?
What Year was the first public recommendation made by Robert Driscoll?
